BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2423341)

  • 1. The effect of 3-deazauridine and dipyridamole on uridine utilization by mice.
    Moyer JD; Malinowski N; Cysyk RL
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):323-7. PubMed ID: 2423341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
    Karle JM; Cysyk RL
    Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
    Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
    Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of 3-deazauridine in mice.
    Cysyk RL; Gormley PE; D'Anna ME; Adamson RH
    Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
    Darnowski JW; Handschumacher RE; Wiegand RA; Goulette FA; Calabresi P
    Biochem Pharmacol; 1991 Jun; 41(12):2031-6. PubMed ID: 2039551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
    McPartland RP; Wang MC; Bloch A; Weinfeld H
    Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653
    [No Abstract]   [Full Text] [Related]  

  • 10. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
    Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
    Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
    Belt JA
    Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo.
    Cysyk RL; Malinowski N; Marquez V; Zaharevitz D; August EM; Moyer JD
    Biochem Pharmacol; 1995 Jan; 49(2):203-7. PubMed ID: 7840797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
    Mills-Yamamoto C; Lauzon GJ; Paterson AR
    Biochem Pharmacol; 1978 Jan; 27(2):181-6. PubMed ID: 623673
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
    Drake JC; Hande KR; Fuller RW; Chabner BA
    Biochem Pharmacol; 1980 Mar; 29(5):807-11. PubMed ID: 20227960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
    Jackson RC; Williams JC; Weber G
    Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of uridine incorporation into RNA in mammalian cells by agents affecting the properties of the cell membrane: chloropromazine, dipyridamole and phenylethanol.
    Crifò C; Bozzi A; Mondoví B; Strom R
    Biochem Pharmacol; 1973 Oct; 22(20):2511-9. PubMed ID: 4763587
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of uridine kinase and the salvage of uridine by modified pyrimidine nucleosides.
    Moyer JD; Karle JM; Malinowski N; Marquez VE; Salam MA; Malspeis L; Cysyk RL
    Mol Pharmacol; 1985 Nov; 28(5):454-60. PubMed ID: 2997596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-beta-D-ribofuranosylthiazole-4-carboxamide on uptake of nucleosides by cultured L1210 cells.
    Karle JM; Monks A; Wolfe RM; Cysyk RL
    Cancer Lett; 1984 Aug; 24(1):11-8. PubMed ID: 6498794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-dependent and -independent transport of uridine and its phosphorylation in mouse spleen cells.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1989 Jun; 981(2):315-25. PubMed ID: 2730909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrative uridine transport by murine splenocytes: kinetics, substrate specificity, and sodium dependency.
    Darnowski JW; Holdridge C; Handschumacher RE
    Cancer Res; 1987 May; 47(10):2614-9. PubMed ID: 3567894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.